This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.63% per year. These returns cover a period from January 1, 1988 through December 2, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tenet Healthcare (THC) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of +11.11% and +1.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Universal Health Services (UHS) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of +22.10% and +4.23%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Will Lower Patient Days Affect Tenet Healthcare's Q3 Earnings?
by Zacks Equity Research
THC's third-quarter results may show profit growth despite lower patient days and mixed hospital trends.
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
by Zacks Equity Research
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Tenet Healthcare (THC) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $205.12, moving +1.37% from the previous trading session.
Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $199.23, moving +1.48% from the previous trading session.
Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Tenet (THC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Is Trending Stock Tenet Healthcare Corporation (THC) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Tenet Healthcare (THC) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Tenet Healthcare (THC) concluded the recent trading session at $200.48, signifying a -2.12% move from its prior day's close.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Tenet Healthcare (THC) closed at $203.38, marking a +1.01% move from the previous day.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare Corporation (THC) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Will Fresh Fed Rate Cuts Lift Stocks?
by John Blank
Liquidity is a Major Force in All Risk Markets.
Acadia Healthcare Rockets 12% as Activist Investor Drops the Gauntlet
by Kaibalya Pravo Dey
ACHC jumps 12% as Engine Capital pushes for a bold shake-up. Can a board revamp and smarter capital moves revive the battered stock?
Is Most-Watched Stock Tenet Healthcare Corporation (THC) Worth Betting on Now?
by Zacks Equity Research
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Analyst Blog Highlights Tenet Healthcare, SharkNinja and Evercore
by Zacks Equity Research
Tenet Healthcare, SharkNinja, and Evercore emerge as Zacks #1 Rank stocks amid global uncertainty and shifting macro trends.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare (THC) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the latest trading session, Tenet Healthcare (THC) closed at $194.06, marking a +2.06% move from the previous day.
Fraught Time for a UN General Assembly: Global Week Ahead
by John Blank
There is no shortage of hot-button issues at the annual gathering, which will be dominated by President Trump's return to the rostrum, war in Gaza and Ukraine and nuclear tensions with Iran.
Zacks.com featured highlights include AppLovin, Build-A-Bear Workshop and Tenet Healthcare
by Zacks Equity Research
AppLovin, Build-A-Bear, and Tenet Healthcare earn momentum stock spotlight under the Driehaus investing strategy.